ALLK Archived Articles
Allakos Inc. (ALLK): A Biotech Navigating the Complexities of Immunotherapies
Published on March 13, 2025
Allakos: A Biopharmaceutical Trailblazer Navigating the Frontiers of Mast Cell-Driven Diseases
Published on November 17, 2024
Allakos Inc. (NASDAQ:ALLK): Promising Pipeline, But Significant Challenges Ahead
Published on September 24, 2024